Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Microbiota × Cyclophosphamide × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 467 Lymphoma 380 Precursor Cell Lymphoblastic Leukemia-Lymphoma 351 Leukemia 304 Lymphoma, Large B-Cell, Diffuse 303 Multiple Myeloma 288 Lymphoma, Non-Hodgkin 275 Leukemia, Lymphocytic, Chronic, B-Cell 251 Leukemia, Myeloid, Acute 245 Lymphoma, Follicular 210 Burkitt Lymphoma 190 Myelodysplastic Syndromes 185 Lymphoma, Mantle-Cell 173 Hodgkin Disease 172 Recurrence 133 Lymphoma, B-Cell, Marginal Zone 124 Melanoma 117 Lymphoma, Large-Cell, Immunoblastic 105 Neoplasms 93 Lymphoma, B-Cell 87 Neoplasms, Plasma Cell 86 Ovarian Neoplasms 81 Neuroblastoma 81 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 77 Hematologic Neoplasms 75 Myeloproliferative Disorders 74 Triple Negative Breast Neoplasms 73 Leukemia, Myeloid, Chronic-Phase 73 Dendritic Cell Sarcoma, Interdigitating 72 Leukemia, Myeloid, Accelerated Phase 71

Interventions

Tablets 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04138979 2019-10-25

Intestinal Microbiota of Breast Cancer Patients Undergoing Chemotherapy

First Affiliated Hospital of Harbin Medical University

Microbiota

Data powered by HemOnc (CC BY 4.0) Colophon ⚡